Correction to: Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis

Amalie Thorsti Møller Rønnstad¹, Christopher G Bunick^{2

3}, Raj Chovatiya^{4

5}, Masahiro Kamata⁶, Mia-Louise Nielsen¹, Daniel Isufi⁷, Simon F Thomsen^{1

8}, Christian Vestergaard⁹, Andreas Wollenberg^{10

11

12}, Alexander Egeberg^{1

13}, Jacob P Thyssen^{1

13}, Nikolai Loft¹⁴

Affiliations

¹ Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
² Program in Translational Biomedicine, Yale School of Medicine, Yale University, New Haven, CT, USA.
³ Department of Dermatology, Yale University, New Haven, CT, USA.
⁴ Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
⁵ Center for Medical Dermatology + Immunology Research, Chicago, IL, USA.
⁶ Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
⁷ Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.
⁸ Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁹ Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
¹⁰ Department of Dermatology and Allergy, University Hospital Augsburg, Augsburg, Germany.
¹¹ Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany.
¹² Department of Dermatology and Allergy, Ludwig-Maximilian University, Munich, Germany.
¹³ Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
¹⁴ Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark. nikolai.nguyen.loft@regionh.dk.

Published Erratum

Amalie Thorsti Møller Rønnstad et al. Am J Clin Dermatol. 2025 Jul.

. 2025 Jul;26(4):639.

doi: 10.1007/s40257-025-00948-6.

¹ Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
² Program in Translational Biomedicine, Yale School of Medicine, Yale University, New Haven, CT, USA.
³ Department of Dermatology, Yale University, New Haven, CT, USA.
⁴ Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
⁵ Center for Medical Dermatology + Immunology Research, Chicago, IL, USA.
⁶ Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
⁷ Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.
⁸ Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁹ Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
¹⁰ Department of Dermatology and Allergy, University Hospital Augsburg, Augsburg, Germany.
¹¹ Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany.
¹² Department of Dermatology and Allergy, Ludwig-Maximilian University, Munich, Germany.
¹³ Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
¹⁴ Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark. nikolai.nguyen.loft@regionh.dk.

No abstract available

Erratum for

Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis.
Rønnstad ATM, Bunick CG, Chovatiya R, Kamata M, Nielsen ML, Isufi D, Thomsen SF, Vestergaard C, Wollenberg A, Egeberg A, Thyssen JP, Loft N. Rønnstad ATM, et al. Am J Clin Dermatol. 2025 May;26(3):411-424. doi: 10.1007/s40257-025-00927-x. Epub 2025 Mar 5. Am J Clin Dermatol. 2025. PMID: 40045152